SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006445
Filing Date
2017-08-09
Accepted
2017-08-09 16:47:52
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20170630x10q.htm 10-Q 1219558
2 EX-10.1 axsm-20170630ex10181dfc0.htm EX-10.1 45767
3 EX-31.1 axsm-20170630ex311a3dcf7.htm EX-31.1 11435
4 EX-31.2 axsm-20170630ex3124eb98f.htm EX-31.2 11204
5 EX-32.1 axsm-20170630ex321a88694.htm EX-32.1 5906
6 EX-32.2 axsm-20170630ex3220029f2.htm EX-32.2 5891
7 GRAPHIC axsm20170630ex10181dfc0001.jpg GRAPHIC 16769
  Complete submission text file 0001558370-17-006445.txt   3457034

Data Files

Seq Description Document Type Size
8 EX-101.INS axsm-20170630.xml EX-101.INS 560636
9 EX-101.SCH axsm-20170630.xsd EX-101.SCH 24641
10 EX-101.CAL axsm-20170630_cal.xml EX-101.CAL 28630
11 EX-101.DEF axsm-20170630_def.xml EX-101.DEF 46467
12 EX-101.LAB axsm-20170630_lab.xml EX-101.LAB 227420
13 EX-101.PRE axsm-20170630_pre.xml EX-101.PRE 156570
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 171018573
SIC: 2834 Pharmaceutical Preparations